Goldman Targeted by China State Media for Bearish Bank View
A state-owned Chinese newspaper issued a rare rebuttal of Goldman Sachs Group Inc. research after the securities firm’s
2023-07-07 11:27
Binance Executives Exit as the Regulatory Heat on the Largest Crypto Exchange Intensifies
The billionaire founder of crypto’s biggest exchange Binance Holdings Ltd. sought to defend the platform following the exits
2023-07-07 11:22
US Raises Fresh Concern Over China’s ‘Risky’ Sea Moves
The US has expressed concern over China’s recent behavior towards Philippine vessels in the South China Sea, with
2023-07-07 10:47
Yellen to Meet Chinese Premier in Push to Mend Bilateral Ties
US Treasury Secretary Janet Yellen will speak with Chinese Premier Li Qiang in Beijing on Friday afternoon, as
2023-07-07 10:20
China’s Sinking Markets Heap Pressure on Xi to Deliver Stimulus
Chinese authorities are facing pressure to back up their reassuring rhetoric on the economy with more substantive action.
2023-07-07 10:17
House Republicans Probe BlackRock, Vanguard on Their ESG Policies
House Judiciary Chairman Jim Jordan and two other House Republicans fired off letters to financial industry giants including
2023-07-07 09:52
Japan Wage Growth Doubles Estimates, Feeding BOJ Speculation
Japanese workers’ wages jumped by more than twice the pace expected by economists as annual pay hikes fed
2023-07-07 09:45
The US is the world's biggest corn exporter - but for how long?
The US could soon lose its title as the world's biggest exporter of the crop, which could have global consequences.
2023-07-07 09:29
Brazil’s Congress Advances First Major Tax Overhaul in Decades
Brazil’s lower house gave preliminary approval to a proposal to overhaul the country’s labyrinthine tax rules, a goal
2023-07-07 09:22
Twitter Settles Retaliation Claim Over Return to Office Protest
Twitter has settled with a former employee who US labor board prosecutors concluded was illegally punished for protesting
2023-07-07 08:53
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move that will help widen insurance
2023-07-07 08:48
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46